Skip to main content
Evidence, Guidelines, Mechanisms, and Trials Supporting Biologics-Based
Targeting of Type 2 Cytokine Signaling Proteins for Moderate-to-Severe AD in
Children, Adolescents and Adults
A Year 2020 Clinical Practice Roadmap for the Pediatric and Adult Dermatology Specialist, Clinical Immunologist, Adolescent Physician, Allergist, Pediatrician and Related Specialists LEARN MORE >
Importance of Early Diagnosis, Testing, and Recognition of Unusual and Heterogeneous Symptoms and Hallmarks of

Fabry Disease Across Multiple Clinical Specialties
A Year 2020 Diagnostic, Assessment, and Fabry Disease Management Update for the GI, Neurological, Renal, CV, Dermatologic and Clinical Genetics Specialist LEARN MORE >
Therapeutic Advances, Novel Formulations and Patient Adherence for Optimizing Management of
Focus on the Safety, Evidence and Rationale for Inhaled Antimicrobial Suspension LEARN MORE >
ECP in CTCL, GVHD, Solid Organ Transplant Rejection, and Scleroderma Focus on the Evidence and Clinical Applications at the Front Lines of Patient Care LEARN MORE >
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction Focus on Trial-Based Evidence for PCSK9-Mediated LDL-C Lowering to Optimize Treatment and Prevention of ASCVD LEARN MORE >
CV Risk Reduction and Glycemic Control in TD2 Focus on GLP-1 RAs and Combination Insulin Formulations to Optimize Glycemic Control and Reduce Cardiovascular Events LEARN MORE >
Optimizing Glycemic Regulation Through Combination Therapy Focus on the Safety, Convenience,  HA1c Control, Reducing Risk of Hypoglycemia, and Efficacy of Combination Basal Insulin-GLP-1 RA Regimens in T2D LEARN MORE >
Focus on IL-6 Inhibitors for Optimizing Multimodal Management of RA A Real World Approach to Unmet Needs, Patient-Centric Care, Special Populations, and Sequencing Biologic Therapies for Rheumatoid Arthritis (RA) LEARN MORE >

Featured Specialties